White Paper

6 Pages
  • 6 Pages

“Let Patients Choose”: Jurors’ COVID-Era Opinions of the Pharmaceutical Industry – Part 2

 

Learn why choice matters.

It is heard repeatedly in practice trials – having a choice. The power to make an informed decision. When a person is dealing with an illness or an injury, they may feel like they don’t have any control. If no one is directly responsible for their pain, they may transfer that anger elsewhere, including pharmaceutical manufacturers. The injured person may feel like drug costs are too high or that their medication risks weren’t properly explained. Jurors often take a dim view of anything that seems to deny consumers the right to make an informed decision about their health care. This white paper reviews the findings on jurors’ expectations for the pharmaceutical industry in a post-COVID-19 world and discusses how you can counter legal challenges.